Journal of Pharmaceutical Policy and Practice

译名:药物政策与实践期刊

ESCIJCR Q2

1-3

2026

影响因子区间

平台估算

投稿周期

12%

2025

中国作者发文占比

2433 GBP

费用说明

收费

期刊简介:Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review ) is an Open Access peer-reviewed journal that provides a platform for researchers to disseminate empirical research findings with the aim that people everywhere have access to the medicines they need and be able to use them rationally. The journal encompasses all aspects of pharmacy including clinical, social, administration, and economics. It also covers pharmaceutical aspects of healthcare policy, providing a platform to researchers, academics and practitioners from around the world to share evidence, concerns and perspectives on pharmacy systems, management, ethics, and financial analysis. Journal of Pharmaceutical Policy and Practice welcomes for consideration the following types of article: research article, letter to the Editor, review, article commentary, comment, policy analysis, short report, study protocol. All articles received by the journal will be subject to double-anonymous peer review. Journal History In December 2008, Southern Med Review was started by Prof. Zaheer Babar to promote pharmaceutical policy research at a global level. The journal has been unique in publishing the work of new researchers, documenting the pharmaceutical situation of low- and middle-income countries and debating pertinent pharmaceutical policy questions. The journal's work has been recognized at a global level and, according to WHO, it fulfilled a global need. The journal is indexed in Scopus, EMBASE and PubMed Central and in 2013 was relaunched under its new title, Journal of Pharmaceutical Policy and Practice . Archival content An electronic archive of content under the journal's previous name Southern Med Review Volumes 2-5 (2009-2012) can be found on PubMed Central . About the Editor Professor Zaheer-Ud-Din Babar is a Professor of Clinical Pharmacy and Practice at College of Pharmacy, Qatar University,and a Visiting Professor in the Department of Pharmacy at the University of Huddersfield, United Kingdom. He has held several senior academic leadership roles, including Professor of Medicines and Healthcare and Director of the Pharmaceutical Policy and Practice Research Centre at the University of Huddersfield (2017–2023), and Head of Pharmacy Practice at the University of Auckland, New Zealand (2007–2016). He is internationally recognised for his work in pharmaceutical policy and practice, particularly in the quality use of medicines, clinical pharmacy practice, equitable access to medicines, and pharmacoeconomics.

【译文】《药物政策与实践杂志》(原名《南方医学评论》)是一本开放获取的同行评审期刊,为研究人员提供了传播实证研究结果的平台,旨在让世界各地的人们都能获得他们需要的药物并能够合理使用它们。该杂志涵盖药学的各个方面,包括临床、社会、管理和经济学。它还涵盖医疗保健政策的制药方面,为世界各地的研究人员、学者和从业人员提供一个平台,分享有关药房系统、管理、道德和财务分析的证据、担忧和观点。 《药物政策与实践杂志》欢迎考虑以下类型的文章:研究文章、致编辑的信、评论、文章评论、评论、政策分析、简短报告、研究方案。该期刊收到的所有文章都将接受双匿名同行评审。期刊历史 2008 年 12 月,Zaheer Babar 教授创办了《南方医学评论》,旨在促进全球范围内的药物政策研究。该杂志在发表新研究人员的工作、记录低收入和中等收入国家的制药状况以及辩论相关的制药政策问题方面是独一无二的。该杂志的工作得到了全球的认可,据世界卫生组织称,它满足了全球的需求。该期刊已被 Scopus、EMBASE 和 PubMed Central 索引,并于 2013 年以新标题“Journal of Pharmaceutical Policy and Practice”重新推出。档案内容 可以在 PubMed Central 上找到该期刊以前名称 Southern Med Review Volumes 2-5 (2009-2012) 下内容的电子档案。关于编辑 Zaheer-Ud-Din Babar 教授是卡塔尔大学药学院临床药学与实践教授,也是英国哈德斯菲尔德大学药学系客座教授。他曾担任多个高级学术领导职务,包括哈德斯菲尔德大学医药与医疗保健教授、医药政策与实践研究中心主任(2017-2023 年)以及新西兰奥克兰大学药学实践负责人(2007-2016 年)。他因其在药物政策和实践方面的工作而获得国际认可,特别是在药物的质量使用、临床药学实践、药物的公平获取和药物经济学方面。

出版社
BioMed Central
语言
English
学科
经济学 / 医学 / 法学
ISSN
2052-3211
eISSN
2052-3211
出版频率
年刊
创刊年份
1979
投稿网址
https://joppp.biomedcentral.com/
最近更新
2026-04-02 18:16:40
Journal of Pharmaceutical Policy and Practice

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间1-3
暂无